Federal Register / Vol. 75, No. 199 / Friday, October 15, 2010 / Notices 63495 

Time: 9 a.m. to 6 p.m. 

Agenda: Director’s Report: Ongoing and 

New Business; Reports of Program Review 

Group(s); and Budget Presentations; Reports 

of Special Initiatives; RFA and RFP Concept 

Reviews; and Scientific Presentations. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, 6th Flr., Conf. 

Room 10, Bethesda, MD 20892. 

Contact Person: Paulette S. Gray, PhD, 

Executive Secretary, Director, Division of 

Extramural Activities, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Boulevard, 8th Floor, Rm. 8001, 

Bethesda, MD 20892, 301–496–5147, grayp@

mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s\Center’s home page: http:// 

deainfo.nci.nih.gov/advisory/bsa.htm, where 

an agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: October 5, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–26032 Filed 10–14–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, Kidney Diseases in 

Children Ancillary Studies. 

Date: November 4, 2010. 

Time: 4 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Carol J. Goter-Robinson, 

PhD, Scientific Review Officer, Review 

Branch, DEA, NIDDK, National Institutes of 

Health, Room 748, 6707 Democracy 

Boulevard, Bethesda, MD 20892–5452, (301) 

594–7791, goterrobinsonc@

extra.niddk.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, DDK–C Conflicts. 

Date: November 16, 2010. 

Time: 1:30 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Lakshmanan Sankaran, 

PhD, Scientific Review Officer, Review 

Branch, DEA, NIDDK, National Institutes of 

Health, Room 755, 6707 Democracy 

Boulevard, Bethesda, MD 20892–5452, (301) 

594–7799, ls38z@nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, Gastroparesis 

Consortium. 

Date: November 18, 2010. 

Time: 2:30 p.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Maria E. Davila-Bloom, 

PhD, Scientific Review Officer, Review 

Branch, DEA, NIDDK, National Institutes of 

Health, Room 758, 6707 Democracy 

Boulevard, Bethesda, MD 20892–5452, (301) 

594–7637, davila-bloomm@

extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: October 7, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–26031 Filed 10–14–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Partnerships To Advance the National 

Occupational Research Agenda 

(NORA) 

AGENCY: The National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice of public meeting. 

SUMMARY: The National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC) 

announces the following public 

meeting: ‘‘Partnerships to Advance the 

National Occupational Research Agenda 

(NORA)’’. 

Public Meeting Time and Date: 10 

a.m.–3:30 p.m. EST, January 26, 2011. 

Place: Patriots Plaza, 395 E Street, 

SW., Conference Room 9000, 

Washington, DC 20201. 

Purpose of the Meeting: The National 

Occupational Research Agenda (NORA) 

has been structured to engage partners 

with each other and/or with NIOSH to 

advance NORA priorities. The NORA 

Liaison Committee continues to be an 

opportunity for representatives from 

organizations with national scope to 

learn about NORA progress and to 

suggest possible partnerships based on 

their organization’s mission and 

contacts. This opportunity is now 

structured as a public meeting via the 

Internet to attract participation by a 

larger number of organizations and to 

further enhance the success of NORA. 

Some of the types of organizations of 

national scope that are especially 

encouraged to participate are employers, 

unions, trade associations, labor 

associations, professional associations, 

and foundations. Others are welcome. 

This meeting will include updates 

from NIOSH leadership on NORA as 

well as updates from approximately half 

of the NORA Sector Councils on their 

progress, priorities, and implementation 

plans to date, including the NORA 

Agriculture, Forestry, and Fishing; 

Healthcare and Social Assistance; 

Mining; Oil and Gas Extraction; and 

mstockstill on DSKH9S0YB1PROD with NOTICES

63496 Federal Register / Vol. 75, No. 199 / Friday, October 15, 2010 / Notices 

Transportation, Warehousing, and 

Utilities Sector Councils. Updates will 

also be given on the Mid-Decade Review 

of NORA and the NORA Symposium 

2011. After each update, there will be 

time to discuss partnership 

opportunities. 

Status: The meeting is open to the 

public, limited only by the capacities of 

the conference call and conference room 

facilities. There is limited space 

available in the meeting room (capacity 

34). Therefore, information to allow 

participation in the meeting through the 

Internet (to see the slides) and a 

teleconference call (capacity 50) will be 

provided to registered participants. 

Participants are encouraged to consider 

attending by this method. Each 

participant is requested to register for 

the free meeting by sending an e-mail to 

noracoordinator@cdc.gov containing the 

participant’s name, organization name, 

contact telephone number on the day of 

the meeting, and preference for 

participation by Web meeting 

(requirements include: computer, 

Internet connection, and telephone, 

preferably with ‘mute’ capability) or in 

person. An e-mail confirming 

registration will include the details 

needed to participate in the Web 

meeting. Non-US citizens are 

encouraged to participate in the Web 

meeting. Non-US citizens who do not 

register to attend in person on or before 

January 7, 2011, will not be granted 

access to the meeting site and will not 

be able to attend the meeting in-person 

due to mandatory security clearance 

procedures at the Patriots Plaza facility. 

Background: NORA is a partnership 

program to stimulate innovative 

research in occupational safety and 

health leading to improved workplace 

practices. Unveiled in 1996, NORA has 

become a research framework for the 

nation. Diverse parties collaborate to 

identify the most critical issues in 

workplace safety and health. Partners 

then work together to develop goals and 

objectives for addressing those needs 

and to move the research results into 

practice. The NIOSH role is facilitator of 

the process. For more information about 

NORA, see http://www.cdc.gov/niosh/ 

nora/about.html. 

Since 2006, NORA has been 

structured according to industrial 

sectors. Ten major sector groups have 

been defined using the North American 

Industrial Classification System 

(NAICS). After receiving public input 

through the Web and town hall 

meetings, ten NORA Sector Councils 

have been working to define sectorspecific strategic plans for conducting 

research and moving the results into 

widespread practice. During 2008–10, 

most of these Councils posted draft 

strategic plans for public comment and 

eight have posted finalized National 

Sector Agendas after considering 

comments on the drafts. For the 

National Sector Agendas, see http:// 

www.cdc.gov/niosh/nora/. 

FOR FURTHER INFORMATION CONTACT: 

Sidney C. Soderholm, Ph.D, NORA 

Coordinator, E-mail 

noracoordinator@cdc.gov, telephone 

(202) 245–0665. 

Dated: October 8, 2010. 

Tanja Popovic, 

Deputy Associate Director for Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2010–25973 Filed 10–14–10; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Arthritis and 

Musculoskeletal and Skin Diseases Special 

Grants Review Committee. 

Date: October 25–26, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Helen Lin, PhD, Scientific 

Review Officer, NIH/NIAMS/RB, 6701 

Democracy Blvd., Suite 800, Plaza One, 

Bethesda, MD 20817, 301–594–4952, 

linh1@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.846, Arthritis, 

Musculoskeletal and Skin Diseases Research, 

National Institutes of Health, HHS) 

Dated: October 8, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–26068 Filed 10–14–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Council for the Elimination of 

Tuberculosis (ACET) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned committee: 

Times and Dates: 

8:30 a.m.–5:30 p.m., November 2, 2010. 

8:30 a.m.–2:30 p.m., November 3, 2010. 

Place: Corporate Square, Building 8, 1st 

Floor Conference Room, Atlanta, Georgia 

30333, telephone (404) 639–8317. 

Status: Open to the public, limited only by 

the space available. The meeting room 

accommodates approximately 100 people. 

Purpose: This council advises and makes 

recommendations to the Secretary of Health 

and Human Services, the Assistant Secretary 

for Health, and the Director, CDC, regarding 

the elimination of tuberculosis. Specifically, 

the Council makes recommendations 

regarding policies, strategies, objectives, and 

priorities; addresses the development and 

application of new technologies; and reviews 

the extent to which progress has been made 

toward eliminating tuberculosis. 

Matters To Be Discussed: Agenda items 

include issues pertaining to TB outbreaks 

within the homeless population; TB issues 

along the U.S.-Mexico border; foreign born 

guidelines update and endorsement; Bacille 

Calmette-Gue ́rin (BCG) guidelines update 

and endorsement; STOP TB USA retreat 

update; and other related tuberculosis issues. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Margie Scott-Cseh, CDC, 1600 Clifton Road, 

NE., Mailstop E–07, Atlanta, Georgia 30333, 

telephone (404) 639–8317. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register Notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: October 6, 2010. 

Elaine Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–25915 Filed 10–14–10; 8:45 am] 

BILLING CODE 4163–18–P 

mstockstill on DSKH9S0YB1PROD with NOTICES